Fireworks: Belgian dispute over ovarian transplant findings includes claims of theft, arson

There’s a story brewing in Belgium that is, as one local newspaper put it, worthy of a TV drama. Here’s our attempt at a summary: Jacques Donnez, chair of Catholic University of Louvain’s (UCL) gynecology department, and colleagues published two studies in Human Reproduction in 2010. One study claimed to show that a woman had given birth … Continue reading Fireworks: Belgian dispute over ovarian transplant findings includes claims of theft, arson

Biochemistry journal retracts paper for being, well, less than conclusive

Here’s a new one that may stoke the debate about whether a paper deserves retraction merely for being wrong or less than fully right. The journal Cell Biochemistry and Function, a Wiley title, has retracted an article it published earlier this year by a pair of Chinese authors — or, rather, from one author an … Continue reading Biochemistry journal retracts paper for being, well, less than conclusive

Brazil statement urges culture of research integrity

As its research institutions grow and mature, the Brazilian scientific establishment is hoping its scientists encourage research integrity and responsible conduct of research. In late May, Ivan was invited to Brazil to take part in the Second Brazilian Meeting on Research Integrity, Science and Publication Ethics(II BRISPE). Organized by the Medical Biochemistry Institute (IBqM/UFRJ) & … Continue reading Brazil statement urges culture of research integrity

Amarin pulls a Romney: For the second time in a week, premature news of FDA drug approval posted, then retracted

There is apparently a special this week on websites posting news of drug approvals before they actually happen. On Monday, USA Today inadvertently posted a story about the approval of Qsymia, a weight loss drug, several hours before the FDA made an announcement. Today, Amarin, which makes a compound designed to lower triglycerides, put up … Continue reading Amarin pulls a Romney: For the second time in a week, premature news of FDA drug approval posted, then retracted

USA Today posts story on approval of diet drug too soon, takes it down

USA Today has yanked back a story about a diet drug’s approval by the FDA — because the FDA hasn’t actually approved the drug yet. The FDA is scheduled to announce its decision on the subject of the story — Vivus’ Qnexa — today. The decision has been closely watched. The story, headlined “New diet … Continue reading USA Today posts story on approval of diet drug too soon, takes it down

How can institutions prevent scientific misconduct?

There has been plenty of interest in scientific fraud and misconduct lately — and not just on Retraction Watch — from major news outlets and government agencies, among other parties. The rate of retractions is increasing, and some fraudsters are even setting new records. That has focused attention on how institutions can prevent misconduct — … Continue reading How can institutions prevent scientific misconduct?

Group retracts microRNA paper after realizing reagent was skewing results

A retraction from a high-profile group uncovered a technical limitation involving a widely used reagent. Some quick background: the sequence hypothesis central hypothesis dogma of biology states that DNA gets transcribed to RNA that gets translated into proteins. Some RNAs, however, don’t code for proteins, but instead help to regulate gene expression. These microRNAs are tiny … Continue reading Group retracts microRNA paper after realizing reagent was skewing results

Another opaque notice from the JBC, for paper author says is correct and valid

The Journal of Biological Chemistry has posted another of its inscrutable and opaque retraction notices, this one for a study first published in September 2011. The retraction reads in full:

Science has “not asked for a correction or retraction” of arsenic life paper, and why situation is unlike XMRV-CFS

The science world has been abuzz with news that a 2010 Science paper on an arsenic-based strain of bacteria had been refuted by two new studies published Sunday night. Yesterday on Retraction Watch, David Sanders argued the paper should still be retracted. So we were curious whether the editors of the journal had ever asked … Continue reading Science has “not asked for a correction or retraction” of arsenic life paper, and why situation is unlike XMRV-CFS

A first? Papers retracted for citation manipulation

In what appears to be a first, two papers have been retracted for including citations designed to help another journal improve its impact factor rankings. The articles in The Scientific World Journal cited papers in Cell Transplantation, which in turn appears to have cited to a high degree other journals with shared board members. Here’s … Continue reading A first? Papers retracted for citation manipulation